FENDRR is transcribed from the FOXF1 promoter and considered to be one of the favorable lncRNA biomarkers for various cancers, such as liver cancer [12], lung squamous cell carcinoma [13], bladder cancer [14], gastric cancer [15] and lung adenocarcinoma [16]. This evidence concerns the gene FOXF1 and gastric cancer.